AbbVie Inc.’s blockbuster drug Humira will remain available to members of UnitedHealth Group Inc.’s pharmacy benefits manager alongside up to three other similar medications, as one of the world’s top-selling treatments faces its first competitors in the US next year.
Nearly 15,000 independent pharmacies will have a chance to rejoin the Tricare retail pharmacy network, according to officials with Express Scripts. The move comes in response to the Kroger grocery chain’s Sept. 30 announcement that its 2,200 pharmacies in 35 states would no longer participate in the Tricare provider network, officials said.
New York CNN Business — Walmart agreed to the framework of a $3.1 billion settlement, which resolves allegations from multiple states' attorneys general that the company failed to regulate opioid prescriptions contributing to the nationwide opioid crisis.
An FDA advisory panel voted 5-to-8 to recommend rejecting a new drug for patients hospitalized with Covid-19, ruling that a glimmer of potential life-saving benefit couldn't make up for a long list of questions around the company's main trial.
U.S. drugmaker Clovis Oncology (CLVS.O) said on Wednesday it was likely to file for bankruptcy "in the very near term", as the company struggles to sell its cancer drug Rubraca. Sales of Rubraca, Clovis's only approved drug, have been hit in recent years by intensifying competition from rival ovarian cancer treatments, and partly by lower cancer diagnoses during the COVID-related lockdowns.
